Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
International investment agreement wikipedia , lookup
Startup company wikipedia , lookup
Corporate venture capital wikipedia , lookup
Investment banking wikipedia , lookup
Private money investing wikipedia , lookup
Early history of private equity wikipedia , lookup
Socially responsible investing wikipedia , lookup
History of investment banking in the United States wikipedia , lookup
Investment management wikipedia , lookup
Environmental, social and corporate governance wikipedia , lookup
MIND THE BYTE CONCLUDES THE BIGGEST ROUND OF BIOTECH CROWD-EQUITY IN SPAIN, ACHIEVING €234,310 THROUGH THE CROWDCUBE PLATFORM The bioinformatics company, located at the Barcelona Science Park and the Copenhagen Bio Science Park, has passed into the realm of overfunding with 234% of the initial investment objective thanks to over one hundred investors The funds are intended to boost the international marketing of its SaaS platform, which reduces the time and cost of developing new drugs by up to 30% Barcelona, 29 October 2015.- In just 43 days, bioinformatics company Mind the Byte, which specializes in products and services for computational drug design and is located in the Barcelona Scientific Park (PCB), has concluded an investment round totalling €234,310 through the crowdequity platform (for investment crowdfunding) Crowdcube. This figure represents not only more than double the funding target set by the company (234%), but it is also the largest round of crowd-equity achieved in the biotech industry in Spain, with 115 private investors. The average investment amount was €2,037, with a maximum investment of €80,000. The capital is intended to consolidate the plan for expansion and internationalization of Mind the Byte, for which company has relied on the strategic support of ACCIÓ of the Government of Catalonia, Copenhagen Capacity and Invest in Denmark. The first step was to establish a subsidiary in the Copenhagen Bio Science Park (COBIS), one of the most dynamic European clusters in terms of scientific innovation and technological transfer. The second step will be to "boost the marketing of our SaaS platform for drug discovery in countries like the United States, Denmark, Germany and Japan" explains Dr. Alfons Nonell-Canals, Founder and CEO of Mind the Byte. The SaaS platform (Software as a Service), which operates on a pay-per-use basis and employs the latest software, was developed by Mind the Byte in order to break through the major technological and economic barriers of computational design for biotech and pharmaceutical companies and research centres. "We help to speed up the time to market of new drugs by as much as 1 to 3 years," says Nonell-Canals. Pepe Borrell, Executive Director of Crowdcube in Spain, says that Mind the Byte is just the beginning of alternative financing for biotech companies: “Crowdcube investors strongly believe in the development of these companies and support the importance of their business in today's society". This is the second time Mind the Byte has expanded its capital, in late 2014 it completed a round of €200,000 under the leadership of the InKemia IUCT Group. Recently, the company received funding from the H2020 SME Instrument of the European Commission for DataNimbus, its personalized Big Data medicine project. About Mind the Byte Mind the Byte was founded in 2011 by Alfons Nonell-Canals, who holds a PhD in computational chemistry and is a specialist in computer-assisted drug design and analysing large amounts of chemical and biological data. The company, located in the Barcelona Science Park, has two lines of business: developing and marketing next-generation software through the SaaS (Software as a Service) technological platform on a pay-per-use basis—for which it is a pioneer in the market—, and custom services involving computational chemistry for biotechnology and pharmaceutical companies, institutions, and research groups around the world that are committed to reducing the cost of the processes of drug research and development (drug discovery) and accelerating the time to market of new medications (by between 1 and 3 years). Since 2013, Mind the Byte has been a technological partner of Amazon Web Services and a member of the Microsoft BizSpark Plus programme. About Crowdcube Crowdcube is a platform for crowd-equity (investment crowdfunding) founded in the UK, and one of the largest networks of investors around the world. Since 2011, Crowdcube has boasted a global portfolio of more than 220,000 registered investors, and has funded nearly 300 companies for a total of €160 million. Crowdcube makes it possible for anybody to invest alongside professional investors, business angels, venture capital funds, and public institutions. Since July 2014, when Crowdcube began operations in Spain, the platform channelled some €2.6 million to seventeen companies. Currently, it is in the process of registering with the National Securities Market Commission -CNMV, as a participatory financing platform. ........ Photo: Oriol Sans, manager of the ACCIÓ Financing Division, an agency of the Government of Catalonia in charge of the corporate competitiveness; Jordi Alberch, Vice Chancellor for Research, Innovation and Transfers of the UB; Alfons Nonell-Canals, founder and CEO of Mind the Byte; Albert Garcia-Pujadas, member of the board of directors of Mind the Byte and CEO of Foxize School; and Pepe Borrell, executive director of Crowdcube Spain at the presentation of the crowd-equity campaign on 15 September at the PCB - © Mind the Byte, Jordi Cabanas ......... For more information: Mind the Byte Gemma Escarré (Communications Office) Mobile +34 667 76 15 24 [email protected]